Genetic variants in C‐type lectin genes are associated with colorectal cancer susceptibility and clinical outcome. Issue 10 (29th May 2013)

• Record Type: Journal Article
• Authors: Lu, Shun; Bevier, Melanie; Huhn, Stefanie; Sainz, Juan; Lascorz, Jesus; Pardini, Barbara; Naccarati, Alessio; Vodickova, Ludmila; Novotny, Jan; Hemminki, Kari; Vodicka, Pavel; Försti, Asta
• Is Part Of: International journal of cancer. Volume 133:Issue 10(2013:Nov. 15)
• Page Start: 2325
• Page End: 2333
• Publication Date: 2013-05-29
• Subjects: Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.28251
• Languages: English
• ISSNs: 0020-7136

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Inflammatory responses play a vital role at different stages of colorectal carcinogenesis. C‐type lectins mediate inflammatory/immune responses and participate in immune escape of pathogens and tumors. Our study aimed to evaluate the correlation between polymorphisms in three C‐type lectin genes, CD209, MBL2 and REG4, and colorectal cancer (CRC) risk and clinical outcome. We genotyped 15 potentially functional single nucleotide polymorphisms (SNPs) and assessed their associations with CRC risk in a case‐control study of 1353 CRC cases and 767 healthy controls from the Czech Republic. We also analyzed these SNPs in relation to overall and event‐free survival in 414 patients. Two CD209 SNPs were associated with CRC risk after adjustment for multiple comparison. Minor allele carriers of the promoter SNP rs2287886 had an increased risk of CRC (OR 1.30, 95% CI 1.08–1.56), while minor allele carriers of the 3′UTR SNP, rs7248637, had a decreased risk (OR 0.74, 95% CI 0.60–0.91). Multivariate survival analyses, including age, gender, TNM stage and grade, showed that patients without distant metastasis at the time of diagnosis and carrying the rs2994809 T allele had a decreased overall and event‐free survival (HR 2.11, 95% CI 1.20–3.72 and HR 2.00, 95% CI 1.18–3.39, respectively). We show that SNPs in CD209 may affect CRC risk, while a SNP in REG4 may be a useful marker for CRC progression.</p> </abstract>